October 2014
Volume 55, Issue 10
Research Highlight  |   October 2014
Enhancing Reliability of the Laser-Induced Choroidal Neovascularization Mouse Model: Insights From a New Study
Investigative Ophthalmology & Visual Science October 2014, Vol.55, 6535. doi:10.1167/iovs.14-15615
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jing Chen; Enhancing Reliability of the Laser-Induced Choroidal Neovascularization Mouse Model: Insights From a New Study. Invest. Ophthalmol. Vis. Sci. 2014;55(10):6535. doi: 10.1167/iovs.14-15615.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements
The laser-induced choroidal neovascularization (CNV) mouse model is widely used in neovascular age-related macular degeneration (AMD) research. Developed originally in primates, 1 this model was later adapted to rodents 2 and has been successful in predicting the therapeutic value of anti-VEGF therapies, 3 now approved for treating wet AMD. Yet the reliability of this model in producing consistent CNV lesions is debatable, complicated by many factors: differences in laser parameters and operators, rodent age, sex, background, and lesion analytic methods, as well as variations in inclusion and exclusion criteria—all of which together may impact CNV development or accurate measurement of CNV lesions. 
The paper by Poor and colleagues 4 summarizes a massive number of carefully controlled and analyzed laser-induced CNV studies with large numbers of repeated experiments in mice. First, Poor et al. 4 attempted to replicate several previous reports of interventions suggesting suppression of laser-induced CNV development—inhibition of complement pathway (C3 and C5) and small interfering RNA (siRNA) treatment (21mer), as well as anti-VEGF treatments. Except for anti-VEGF treatments, which consistently suppressed CNV, Poor et al. 4 were unable to reproducibly repeat the effects of other examined factors. This study also thoroughly analyzed the influence of genetic background of mice on CNV development and found major variations using mice from different vendors. Based on these results, Poor et al. 4 propose a set of recommendations for both appropriate experimental design and preset lesion inclusion/exclusion criteria to enhance reproducibility and avoid potential pitfalls of the laser-induced CNV model. This study will be a sound reference for many AMD researchers utilizing this model and is likely to improve the reliability of reported results. It is critical to note that there are fundamental pathophysiological differences in this acute thermal-induced VEGF-dependent injury model versus chronic aging in AMD. Thus caution is needed in interpreting the results from non-VEGF-related interventions in laser-induced CNV with respect to relevance to human AMD. 
Ryan SJ. The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc . 1979; 77: 707–745. [PubMed]
Lambert V, Lecomte J, Hansen S Lecomte J Hansen S Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat Protoc . 2013; 8: 2197–2211. [CrossRef] [PubMed]
Krzystolik MG, Afshari MA, Adamis AP Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol . 2002; 120: 338–346. [CrossRef] [PubMed]
Poor SH Qiu Y Fassbender ES Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation. Invest Ophthalmol Vis Sci . 2014; 55: 6525–6534. [CrossRef] [PubMed]

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.